Your browser doesn't support javascript.
loading
Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.
Cheng, Chao; Hong, Wei; Li, Yafang; Xiao, Xiangjun; McKay, James; Han, Younghun; Byun, Jinyoung; Peng, Bo; Albanes, Demetrios; Lam, Stephen; Tardon, Adonina; Chen, Chu; Bojesen, Stig E; Landi, Maria T; Johansson, Mattias; Risch, Angela; Bickeböller, Heike; Wichmann, H-Erich; Christiani, David C; Rennert, Gad; Arnold, Susanne; Goodman, Gary; Field, John K; Davies, Michael P A; Shete, Sanjay S; Le Marchand, Loic; Liu, Geoffrey; Hung, Rayjean J; Andrew, Angeline S; Kiemeney, Lambertus A; Zhu, Meng; Shen, Hongbing; Zienolddiny, Shan; Grankvist, Kjell; Johansson, Mikael; Cox, Angela; Hong, Yun-Chul; Yuan, Jian-Min; Lazarus, Philip; Schabath, Matthew B; Aldrich, Melinda C; Brennan, Paul; Li, Yong; Gorlova, Olga; Gorlov, Ivan; Amos, Christopher I.
Affiliation
  • Cheng C; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Hong W; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
  • Li Y; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Xiao X; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
  • McKay J; Section of Genetics, International Agency for Research on Cancer, WHO, Lyon, France.
  • Han Y; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Byun J; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Peng B; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Lam S; Department of Integrative Oncology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tardon A; Public Health Department, University of Oviedo, ISPA and CIBERESP, Asturias, Spain.
  • Chen C; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Bojesen SE; Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Johansson M; Section of Genetics, International Agency for Research on Cancer, WHO, Lyon, France.
  • Risch A; Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria.
  • Bickeböller H; Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany.
  • Wichmann HE; Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany.
  • Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Rennert G; Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  • Arnold S; University of Kentucky, Markey Cancer Center, Lexington, Kentucky.
  • Goodman G; Swedish Cancer Institute, Seattle, Washington.
  • Field JK; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Davies MPA; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Shete SS; Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
  • Liu G; University Health Network- The Princess Margaret Cancer Centre, Toronto, California.
  • Hung RJ; Luenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Andrew AS; Department of Epidemiology, Dartmouth College, Hanover, New Hampshire; Department of Community and Family Medicine, Dartmouth College, Hanover, New Hampshire.
  • Kiemeney LA; Radboud University Medical Center, Nijmegen, The Netherlands.
  • Zhu M; Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
  • Shen H; Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
  • Zienolddiny S; National Institute of Occupational Health, Oslo, Norway.
  • Grankvist K; Department of Medical Biosciences, Umeå University, Umeå, Sweden.
  • Johansson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
  • Cox A; Academic Unit of Clinical Oncology University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield, United Kingdom.
  • Hong YC; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yuan JM; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington.
  • Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Aldrich MC; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Brennan P; Section of Genetics, International Agency for Research on Cancer, WHO, Lyon, France.
  • Li Y; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Gorlova O; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Gorlov I; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Amos CI; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. El
J Thorac Oncol ; 18(8): 1003-1016, 2023 08.
Article in En | MEDLINE | ID: mdl-37150255
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Thorac Oncol Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Thorac Oncol Year: 2023 Document type: Article Country of publication: Estados Unidos